Revision history of "Phosphocreatine attenuates doxorubicininduced cardiotoxicity by suppressing oxidative stress along with triggering TAK1 to market myocardial emergency inside vivo along with vitro"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.